Skip to main content
. 2023 Aug 23;55(8):1573–1594. doi: 10.1038/s12276-023-01078-x

Fig. 6. Mechanism underlying immunogenic cell death (ICD).

Fig. 6

This figure illustrates the mechanism of ICD and its potential as a cancer therapeutic strategy. During ICD, dying cells release damage-associated molecular patterns (DAMPs), such as ATP, high-mobility group box 1 (HMGB1), and heat shock proteins (HSPs), which activate dendritic cells (DCs) and other immune cells, promoting antigen presentation and immune activation. Effector T cells release interferon (IFN)-γ and TNFα, which activate other immune cells, such as natural killer cells and macrophages that detect and eliminate cancer cells.